Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy.

Bierer S, Hoffmeister I, Gerss J, Herrmann E, Wülfing C, Sibrowski W, Hertle L, Kelsch R (2011)

In: Journal of Immunotherapy, 34(2).

Research article (journal)

Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.

Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A (2010)

In: Journal of Urology, 183(2).

Research article (journal)

Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib.

Herrmann E, Gerss J, Bierer S, Köpke T, Bolenz C, Hertle L, Wülfing C (2009)

In: Journal of Cancer Research and Clinical Oncology, 135(1).

Research article (journal)

Prospective comparison of sorafenib and sunitinib for second-line treatment of cytokine-refractory kidney cancer patients.

Herrmann E, Bierer S, Gerss J, Köpke T, Hertle L, Wülfing C (2008)

In: Oncology, 74(3-4).

Research article (journal)

DiaPat urine test for prostate cancer. Predictive value for results of transrectal ultrasound-guided prostate biopsies

Oberpenning F, von Knobloch R, Sprute W, Roth S, Rathert M, Bierer S, Gerss J, Semjonow A (2008)

In: Urologe A, 47(6).

Research article (journal)

Publications

Operated by

Top-Links

Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib. Riesenbeck LM, Bierer S, Hoffmeister I, Köpke T, Papavassilis P, Hertle L, Thielen B, Herrmann E (2011) In: World Journal of Urology, 29(6). Research article (journal)
Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy. Bierer S, Hoffmeister I, Gerss J, Herrmann E, Wülfing C, Sibrowski W, Hertle L, Kelsch R (2011) In: Journal of Immunotherapy, 34(2). Research article (journal)
New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2. Ciarimboli G, Holle SK, Vollenbröcker B, Hagos Y, Reuter S, Burckhardt G, Bierer S, Herrmann E, Pavenstädt H, Rossi R, Kleta R, Schlatter E (2011) In: Molecular pharmaceutics, 8(1). Research article (journal)
Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review. Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A (2010) In: Journal of Urology, 183(2). Research article (journal)
Update on systemic therapies of metastatic renal cell carcinoma. Herrmann E, Bierer S, Wülfing C (2010) In: World Journal of Urology, 28(3). Research article (journal)
Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib. Herrmann E, Gerss J, Bierer S, Köpke T, Bolenz C, Hertle L, Wülfing C (2009) In: Journal of Cancer Research and Clinical Oncology, 135(1). Research article (journal)
New therapeutic regimes in metastasic renal-cell carcinoma Bierer S, Hertle L, Nitschmann S (2008) In: ((Bitte Journal prüfen)), 49(1). Research article (journal)
Prospective comparison of sorafenib and sunitinib for second-line treatment of cytokine-refractory kidney cancer patients. Herrmann E, Bierer S, Gerss J, Köpke T, Hertle L, Wülfing C (2008) In: Oncology, 74(3-4). Research article (journal)
The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer. Herrmann E, Stöter E, van Ophoven A, Bierer S, Bolenz C, Hertle L, Wülfing C (2008) In: International Journal of Urology, 15(7). Research article (journal)
DiaPat urine test for prostate cancer. Predictive value for results of transrectal ultrasound-guided prostate biopsies Oberpenning F, von Knobloch R, Sprute W, Roth S, Rathert M, Bierer S, Gerss J, Semjonow A (2008) In: Urologe A, 47(6). Research article (journal)